Furthermore, since Lc2/AD represents the only available model harboring RET rearrangement for NSCLC, we employed TPC1 cells, a papillary thyroid cancer (PTC) cell line carrying CCDC6-RET fusion. The gene discussed is RET; the disease is non-small cell lung carcinoma.